Nya farmaka vid ateroskleros i sikte. Antioxidantia hämmar LDL-modifiering.

Translated title of the contribution: New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification

I. Björkhem, Lars Berglund

Research output: Contribution to journalArticle

Translated title of the contributionNew pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification
Original languageUndefined/Unknown
Pages (from-to)3249-3250, 3255
JournalLakartidningen
Volume86
Issue number39
StatePublished - Sep 27 1989
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this